| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |